LDHA overexpression has been reported in lung adenocarcinoma [39], CAIX in breast cancer [40] and oral squamous cell carcinoma [41], MCT4 in bladder [42] and breast cancer [43], and BSG in acute myeloid leukemia [44]. Here, SLC16A3 is linked to acute myeloid leukemia.